Staff & Contacts List
National Biosafety Month 2017: Sharps Safety and Exposure Response
During 2017's National Biosafety Month, you are encouraged to focus attention on biosafety policies, practices and procedures. Investigators and laboratory managers should raise biosafety awareness, discuss the importance of safety, and seek input on ways to strengthen biosafety practices and procedures in their labs. This year, EH&S is focusing on sharps safety in research and exposure response.
Sharps Safety in Research
Disaster Response (PEAT)
The Pre-Entry Assessment Team (PEAT) is the UW's first responder disaster team that consists of members of EH&S and UW Tacoma Safety and Security.
IATA packing instructions 6502
These materials are used in the training course Shipping Biological Substances Category B Online.
Chemotherapy & Hazardous Drugs
Drugs are classified as hazardous if they may cause cancer, developmental or reproductive toxicity or harm to organs at low doses. They include drugs used for cancer chemotherapy (also called antineoplastics), antiviral drugs, hormones, some bioengineered drugs and other various drugs.
Check the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 to determine if a drug is classified as hazardous.
Clinical Trials
Clinical trials involving the administration of infectious agents or recombinant or synthetic nucleic acids to human study participants requires review and approval by the IBC.
Biohazard Warning Sign
The Biohazard Warning Sign must be affixed to entry doors of the following laboratories/rooms:
- BSL-2/ABSL-2
- BSL-2 with BSL-3 practices/ABSL-2 with ABSL-3 practices
- BSL-3/ABSL-3
BSL-2 with BSL-3 practices labs with approved decontamination procedures to lower containment to BSL-2 must follow the posting requirements in their laboratory-specific standard operating procedures (SOPs).
How to Complete the Biohazard Warning Sign: